Brownlie Keith L 4
4 · Celldex Therapeutics, Inc. · Filed Jun 20, 2019
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-06-19+4,500→ 4,500 totalExercise: $2.78From: 2020-06-19Exp: 2029-06-16→ Common Stock (4,500 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.